Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
CDChristopher D. ByrneAAAngelo ArmandiVPVanessa PellegrinelliAVAntonio Vidal‐PuigEBElisabetta Bugianesi
University Hospital Southampton NHS Foundation Trust · NIHR Southampton Biomedical Research Centre · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
54
total citations
- FWCI
- 57.06
- Percentile
- 100%
- References
- 168
Citations per year
Authors
5- CDChristopher D. ByrneCorresponding
University Hospital Southampton NHS Foundation Trust, NIHR Southampton Biomedical Research Centre, University of Southampton
- AAAngelo Armandi
University of Turin
- VPVanessa Pellegrinelli
University of Cambridge, Wellcome/MRC Institute of Metabolic Science, Centro de Investigacion Principe Felipe
- AVAntonio Vidal‐Puig
University of Cambridge, Wellcome/MRC Institute of Metabolic Science, Centro de Investigacion Principe Felipe
- EBElisabetta Bugianesi
Department of Medical Sciences
Topics & keywords
Topics
Keywords
- Medicine
- Intensive care medicine
- Disease
- Liver dysfunction
- MEDLINE
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.